Pharma Intermediates
| Intermediate Name | API Name | CAS No. | Stage | Image | COA | Pricing | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3-(Hexyloxy)-4-(pyridin-3-yl)-1,2,5-thiadiazole, | Xanomeline | 131987-69-4 | Pilot |
|
No COA | |||||||||||
|
||||||||||||||||
| 3-Chloro-4-(pyridin-3-yl)-1,2,5-thiadiazole | Xanomeline | 131986-28-2 | Pilot |
|
No COA | |||||||||||
|
||||||||||||||||
| 2-((2,4-Dimethylphenyl)thio)aniline | vortioxetine Hydrobromide | 1019453-85-0 | Pilot |
|
No COA | |||||||||||
|
||||||||||||||||
| (2,4-Dimethylphenyl)(2-nitrophenyl)sulfane | vortioxetine Hydrobromide | 1610527-49-5 | Pilot |
|
No COA | |||||||||||
|
||||||||||||||||
| (1-(2-chloroethyl) Urea) | Ensifentrine | 6296-42-0 | Commercial |
|
View COA | |||||||||||
|
||||||||||||||||
| Disclaimer: Products protected by valid patents are not offered where sale constitutes infringement. | ||||||||||||||||